Skip to main content

Genotypic and phenotypic analysis of biofilm formation Staphylococcus epidermidis isolates from clinical specimens

Abstract

Objectives

Staphylococcus epidermidis is the primary causative agent of infections associated with indwelling biomaterials. Antibiotic susceptibility patterns, Biofilm formation capability, and screening of responsible genes in biofilm formation procedure in clinical isolates (icaA, icaB, icaC, icaD, sdrG, and atlE) were assigned as the main objectives in this study. The clinical samples were analyzed via standard biochemical assays for identifying different bacteria which were confirmed using the multiplex colony PCR method. Subsequently, biofilm-formation capability, antibiotic susceptibility testing, and the frequency of genes responsible for biofilm formation in the confirmed strains were checked.

Results

Out of 183 clinical specimens 54 S. epidermidis isolates were detected by targeting a housekeeping gene (sesc) taking advantage of the PCR procedure. All of the strains were Biofilm forming producers. The in vitro biofilm formation assays determined that 45 (83.33%), 5 (9.26%), 4 (7.41%) were strong, moderate, and weak biofilm former strains respectively. Among the isolated strains, the specific frequencies of the biofilm-forming genes were specified to be (98%) for sdrG, (84%) for atlE, (80%) for icaC, and (70%) for icaD. Cefamandole and Amikacin are the most effective antibiotics in isolated strains. All strains were ascertained to be methicillin and amoxicillin/clavulanic acid resistant.

Introduction

Among the CNS, S. epidermidis is the most frequently isolated species accounting for three- quarters of the CNS recovered from clinical specimens and approximately 75% of CNS infections [1]. S. epidermidis was ranked second in surgical site infections. Moreover, because of biofilm-forming capability as the main virulence factor this bacterium implicated in 34% of cases in catheter-related infections (CRIs) in children and 51% in neonates [2, 3]. The recent findings in Iran were shown S. epidermidis isolated strains from various clinical specimens more ubiquitous prevalence in other Iranian cities (73.9%) than Tehran (56.65%) [4]. Other worldwide conducted researches also have shown high isolation rates of the mentioned bacterium in clinical specimens, especially in medical devices samples [5,6,7]. Biofilms are notoriously resistant to immune system responses and antimicrobial agents. They are a huge problem in industry and medicine (responsible for ≈ 65% of all bacterial infections) [8]. Biofilm formation in S. epidermidis was completed by factors including surface proteins such as staphylococcal surface proteins (Ssp-1, Ssp-2), Bap homolog protein (Bhp), autolysin E (AtlE) such as (fibrinogen-binding protein of S. epidermidis) SdrG (Fbe), respectively, and likewise by generating polysaccharide intracellular adhesion by ica Luci [9]. Initial attachment is accomplished by staphylococcal surface proteins e.g. Ssp-1, Ssp-2, bap homolog protein (Bhp), autolysin E (AtlE), and teichoic acids [9]. Indirect binding to the surface of implanted medical devices is done through microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) such as fibrinogen-binding protein of S. epidermidis (SdrG or Fbe), extracellular matrix binding protein (Embp), S. epidermidis lipase protein (GehD), AtlE, and elastin-binding protein of S. aureus (Ebps) [9]. In Staphylococci, the production of polysaccharide intercellular adhesion [PIA, also called poly-N-acetyl glucosamine (PNAG)] by the genes in the intercellular adhesion (ica) operon is the best-understood mechanism [10]. On account of the undeniable role of biofilm formation in S. epidermidis pathogenesis, the prevalence of the mentioned bacterium in clinical specimens and screening of biofilm-related genes in biofilm-forming strains, and their antibiotic susceptibility patterns are main objectives in this study.

Main text

Materials and methods

Isolation and Identification of Staphylococci

A total of 200 clinical specimens including urine, blood, sputum, CSF, pleura, fluid, and wound from three educational hospitals (Sina, Imam Khomeini, and Shariati) were collected from different clinical samples of patients suspected to have a clinical infection from October 2015 to March 2016. Identification was done according to Bergey’s Manual of Determinative Bacteriology guideline [11]. Furthermore, following 24–48 h of incubation at 37 °C on Blood agar, using conventional microbial tests including Gram staining, Capability of mannitol fermentation, production of coagulase enzyme, and susceptibility to novobiocin antibiotic disc were done to differentiate isolates.

Reconfirmation of S. epidermidis isolates

Molecular identification of S. epidermidis was performed by targeting the sesc gene encoding a surface protein specific for S. epidermidis using specifically designed primers which produced a 388 bp PCR product [12]. Amplification was done in a total volume of 25 μl containing 14 μl master amplicon (Biolab, New England, UK), 1 pmol of each forward and reverse primers, a minor amount of colony as a template and 9 μl distilled water. The first cycle of denaturation was at 95 °C for 5 min, followed by 25 cycles at 95 °C for 30 s, then at 55 °C for 1 min, at 72 °C for 1 min, and finally a terminal extension for 5 min. Additional file 1.

Antibiotic susceptibility testing

Susceptibility testing was performed according to the CLSI standard guidelines [13] using the disks (BD BBLTM Sensi DiscTM) containing penicillin 2 µg, amikacin 10 µg, chloramphenicol 30 µg, ciprofloxacin 5 µg, levofloxacin 5 µg, gentamycin 120 µg, kanamycin 30 µg, erythromycin 15 µg, ceftriaxone 30 µg, ceftazidime 30 µg, cefotaxime 30 µg, and cefoxitin 30 µg.

In vitro biofilm formation assay

Biofilm formation capability was accomplished as previously described [14]. Briefly, the optical density of inoculated colonies on the trypticase soy broth was adjusted to the 0.7 in 600 nm. Afterward, 200 μl of 1:200 diluted (OD 0.005 in 600 nm) suspension in trypticase soy broth supplemented with 1% glucose (TSBg) was transferred into a polystyrene microtiter plate (Nunc, Roskilde, Denmark). Following the incubation at 37 °C for 16 h, supernatants and planktonic cells were removed by three times washing with phosphate-buffered saline (PBS). The wells were stained with 150 μl of 0.1% crystal violet and the additional stain was removed by two-times washing with PBS buffer. The optical density of resolved crystal violet in 160 μl alcohol/acetic acid solution (4:1 concentration) was measured at 595 nm. Each sample was tested in triplicate and the ability of biofilm-forming was measured using the following formula. Optical density cut-off value (ODc) = average OD of negative control + 3 × standard deviation (SD) of negative control.

Determining the biofilm-related genes by multiplex colony PCR

In the presence of genes encoding intracellular adhesion (icaA, icaB, icaC, icaD), sdrG, and atlE genes were assessed as previously demonstrated [15]. PCR was performed with a total volume of 50 μl contained 30 μl of master amplicon (Biolab, New England, UK), 1 pmol of each primer, and a minor amount of fresh colony as a template using Gene Amp PCR system (Applied Biosystems, USA). Multiplex colony PCR was carried out in two series: the first series was optimized for the understanding of ica locus genes and the other series were optimized for understanding of sdrG with total volume of 50 μl, containing 30 μl master amplicon (Biolab, New England, UK), 2 pmol of each forward and reverse primers, a negligible amount of colony as the template, and 14 μl distilled water. In the actual utilization of program, the initial cycle of denaturation was carried out at 95 °C for 2 min, followed by 50 cycles at 95 °C for 30 s, then at 54 °C for 1 min (55 °C for sdrG and atlE), at 72 °C for 1 min, 1 min for the final extension, and 7 min for the terminal extension. Resulting PCR was visualized with 3% agarose gel (KBC, Max Pure agarose, Spain). Sequences of utilized primers are detailed in Additional file 2.

Results

Out of 183 staphylococcal isolates recovered from clinical samples, 80 (43.72%) isolates were identified as S. epidermidis using the biochemical procedure. By targeting housekeeping S. epidermidis sequence (sesc gene) out of 80 isolates 54 (29.51%) strains were precisely reconfirmed.

The highest and lowest isolation rates belong to Blood (70%) and bone marrow (0%). Detailed data to S. epidermidis isolates according to the clinical sample sources are specified in Table 1.

Table 1 Frequency of S. epidermidis isolates according to clinical samples

As observed in Additional file 3, the most effective antibiotics were cefamandole (93%) and amikacin 64.4%. Moreover, resistance to penicillin 100%, cefoxitin 95.6%, amoxicillin/clavulanic Acid 88.9% were respectively.

Among all 54 slime producing S. epidermidis strains tested for biofilm formation by quantitative method, 45 (83.33%), 5 (8.26%), and 4 (7.41%) strains exhibited high (\( 4{\text{OD}}_{\text{C}} < OD \)), moderate (\( {\text{OD}}_{\text{C}} < OD < 2O{\text{D}}_{\text{C}} \)), and weak (\( {\text{OD}}_{\text{C}} < OD < 2O{\text{D}}_{\text{C}} \)) levels of biofilm formation, respectively. Tables 2, 3.

Table 2 Frequency of biofilm-related genes in S. epidermidis isolates
Table 3 Patterns of biofilm-related genes in biofilm-forming isolates

While screening for the genes associated with attachment to the host cells, sdrG, atlE, icaC, and icaD (98%, 84%, 80%, and 70%, respectively) were determined to be the predominant genes found within the clinical isolates. These genes were found to occur at a much higher frequency than the icaB and icaA genes (54% and 48%, respectively). Among the strong biofilm-forming isolates, the frequency of fnbA and cna genes were higher than in those of the moderate biofilm-forming strains. Considering the Chi square exact (Fisher exact for atlE) meaningful difference between strong and moderate biofilm producer strains related genes was not observed. Additional files 3, 4.

Discussion

Due to the ubiquitous prevalence of S. epidermidis as a commensal bacterium, it is often difficult for a clinician to decide whether an isolate represents the causative agent of infection or unspecific culture contamination [16]. Considering a systematic review study in Iran isolation rates of S. epidermidis strains in Tehran were reported 99 (2011), 64 (2014), and 20 (2015) [4]. The mentioned study reported that S. epidermidis isolates more prevalent in Tabriz, Arak, Sanandaj than in Tehran. At the current research, the prevalence of S. epidermidis was estimated as 54 (29.51%). Regarding the number of isolates in Tehran, Similar results were observed in the previously published studies. The frequency of S. epidermidis in other studies in Belgium 2013 (33), Africa 2018 (20), and Netherland 2019 (27) were assessed respectively [5,6,7]. Biofilm formation capability could enhance the durability of the mentioned bacterium against disinfection principles in hospitals in the current study [16]. In this research, various capabilities of biofilm formation of S. epidermidis isolates were observed. A baseline has been calculated on three standard deviations: weak, moderate and strong biofilm formers. In this way, merely five (5%) strains out of 50 were mild-biofilm formers (2 × ODc < OD < 4 × ODc) and Forty-five (90%) isolates could be classified as strong biofilm formers (4 × ODc < OD). Observed results happen to be the same as Delpozo and Patel Filho’s findings [8, 17].

In 2016, two different studies investigated clinical isolates of S. epidermidis collected from a private hospital in Tehran [18] and clinical isolates from Shiraz city [19]. Zalipour reported that in 81.9% of clinical isolates of S. epidermidis, ica Luci was observed [19]. Rahimi reported that 82% of the isolated strains were biofilm-formers and all of the biofilm former S. epidermidis isolates carried icaA, icaD, aap, and atlE genes [18]. Granting to the previous findings, [20] sdrG and certain genes have a crucial role in biofilm formation of clinically isolated strains. Our experiments proved and reconfirmed that the mentioned genes have a fundamental role in biofilm formation [20]. Generated PCR products have shown that proteins dependent biofilm formation process is the predominant factor in our isolates. The frequency of generating targeted genes in ica Luci was relatively similar to Dimond’s study [21]. According to the already presented data in a previously published study [15], when the gene profile of clinical isolates of S. epidermidis from orthopedic prosthesis was compared with the phenotypic biofilm-formation ability, 41% of non-biofilm-forming isolates were complete ica negative and only 2% harbored all ica genes. Our findings represented that all 50 S. epidermidis isolates were assigned as biofilm-forming strains. The frequency of determining ica Luci in strong biofilm-forming strains was 51.1% and also 86.7% for both atlE and sdrG genes. Our findings showed that ica Luci, sdrG, and atlE genes could improve the ability of biofilm formation in strong status. Complete or relative resistance to β-lactams is a characteristic feature of the genus staphylococci [14]. An extra problem with staphylococci is that they are typically tolerant of β-lactams (i.e., the MBC/MIC of > 32). The major mechanism underlying this resistance has been documented by the production of low-affinity PBP [14]. Bactericidal antibiotics (e.g., ampicillin or penicillin G), for susceptible strains to penicillin and a glycopeptide (e.g., vancomycin) to which the Staphylococci isolate does not exhibit high-level resistance, are the best drugs of choice for staphylococci infections [22]. Our findings show imipenem could be a proper drug of choice to eradicate bacterial infections caused by S. epidermidis strain. Vancomycin in combination with an aminoglycoside has demonstrated synergistic activity against staphylococci both in vitro and in vivo [22]. However, staphylococci are becoming increasingly resistant to traditional antibiotic therapy. Besides, high-level aminoglycoside resistance and rapid spread of vancomycin resistance have resulted in limited therapeutic alternatives. Our isolated strains showed that the probable 29% and 31% isolates were resistant to gentamycin and vancomycin, respectively. Susceptibility patterns indicated that cefamandole is the best choice of medication for the treatment of S. epidermidis related infections [22]. In conclusion, biofilm-forming S. epidermidis strains owing to the increasing prevalence of antibiotic resistance to β-lactams and aminoglycoside and consumedly usage of antibiotics must be distinguished by the prompt examination method to avoid medical devices related to infections. Hasty identification of affected genes that encoded proteins and polysaccharides in the construction of biofilm has a considerable influence on the multiplex PCR method.

Limitation

The patterns of antibiotic resistance did not show a significant correlation with the biofilm formation and related analyzed strains. It seems that more research is needed for determining the role of genes product in S. epidermidis biofilm formation.

Statistical analysis

In this study, we are using a Chi squared test, (χ2 test). Statistical analysis of results was accomplished by using SPSS version 19 and a P value < 0.05 was considered significant.

Availability of data and materials

All the results of this study have been classified and maintained by the dissertation in the Pasteur Institute of Iran. We have indeed provided all raw data on which our study is based.

References

  1. 1.

    Otto M. Virulence factors of the coagulase-negative staphylococci. Front Biosci. 2004;9:841–63.

    CAS  Article  Google Scholar 

  2. 2.

    Hira V, Sluijter M, Estevão S, Horst-Kreft D, Ott A, de Groot R, Hermans PW, Kornelisse RF. Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates. Pediatr Infect Dis J. 2007;26(7):607–12.

    Article  Google Scholar 

  3. 3.

    Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 2009;23(1):73–98.

    Article  Google Scholar 

  4. 4.

    Razavi S, Dadashi M, Pormohammad A, Khoramrooz SS, Mirzaii M, Gholipour A, Darban-Sarokhalil D. Methicillin-resistant staphylococcus epidermidis in Iran: a systematic review and meta-analysis. Arch Clin Infect Dis. 2018;13(4):e58410.

    Article  Google Scholar 

  5. 5.

    Cherifi S, Byl B, Deplano A, Nonhoff C, Denis O, Hallin M. Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers. J Clin Microbiol. 2013;51(5):1541–7.

    CAS  Article  Google Scholar 

  6. 6.

    Ehlers MM, Strasheim W, Lowe M, Ueckermann V, Kock MM. Molecular epidemiology of Staphylococcus epidermidis implicated in catheter-related bloodstream infections at an Academic Hospital in Pretoria, South Africa. Front Microbiol. 2018;9:417.

    Article  Google Scholar 

  7. 7.

    Ardon C, Prens E, Fuursted K, Ejaz R, Shailes J, Jenssen H, Jemec G. Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions. J Eur Acad Dermatol Venereol. 2019;33(1):170–7.

    CAS  Article  Google Scholar 

  8. 8.

    Del Pozo J, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 2007;82(2):204–9.

    Article  Google Scholar 

  9. 9.

    Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12(1):49–62.

    CAS  Article  Google Scholar 

  10. 10.

    Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun. 1994;62(8):3244–53.

    CAS  Article  Google Scholar 

  11. 11.

    Bergey DH, Holt JG, Krieg P. Bergey’s manual of determinative bacteriology. Baltimore: Williams and Wilkins; 1994. p. 1994.

    Google Scholar 

  12. 12.

    Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PW, Van Eldere J. Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect Immun. 2009;77(9):3670–8.

    CAS  Article  Google Scholar 

  13. 13.

    Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71–9.

    Article  Google Scholar 

  14. 14.

    Stepanović S, Vuković D, Hola V, BONAVENTURA GD, Djukić S, Ćirković I, Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. Apmis. 2007;115(8):891–9.

    Article  Google Scholar 

  15. 15.

    Arciola CR, Gamberini S, Campoccia D, Visai L, Speziale P, Baldassarri L, Montanaro L. A multiplex PCR method for the detection of all five individual genes of ica locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from prosthesis-associated infections. J Biomed Mater Res, Part A. 2005;75(2):408–13.

    Article  Google Scholar 

  16. 16.

    Chabi R, Momtaz H. Virulence factors and antibiotic resistance properties of the Staphylococcus epidermidis strains isolated from hospital infections in Ahvaz, Iran. Trop Med Health. 2019;47(1):56.

    Article  Google Scholar 

  17. 17.

    Filho RGS, Silva AAL, Bento CSM, Saramago CAM, Souza IS, Souza MJ, Carvalho K, Bôas M. Biofilm production by clinical isolates of Staphylococcus epidermidis and its relationship with genotypic profile, presence of virulence-related genes and antibiotic resistance. Afr J Microbiol Res. 2015;9:1026–36.

    Article  Google Scholar 

  18. 18.

    Rahimi F, Karimi S. Biofilm Producing Staphylococcus epidermidis strains isolated from clinical samples in Tehran. Iran. Archives of Clinical Infectious Diseases. 2016;11(3):e33343.

    Google Scholar 

  19. 19.

    Zalipour M, Ebrahim-Saraie HS, Sarvari J, Khashei R. Detection of biofilm production capability and icaA/D genes among staphylococci isolates from Shiraz, Iran. Jundishapur J Microbiol. 2016;9(12):e41431.

    Article  Google Scholar 

  20. 20.

    Klug D, Wallet F, Kacet S, Courcol RJ. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J Clin Microbiol. 2003;41(7):3348–50.

    Article  Google Scholar 

  21. 21.

    Diemond-Hernández B, Solórzano-Santos F, Leaños-Miranda B, Peregrino-Bejarano L, Miranda-Novales G. Production of icaADBC-encoded polysaccharide intercellular adhesin and therapeutic failure in pediatric patients with staphylococcal device-related infections. BMC Infect Dis. 2010;10(1):68.

    Article  Google Scholar 

  22. 22.

    Rahimi F, Bouzari M. Biochemical fingerprinting of methicillin-resistant Staphylococcus aureus isolated from sewage and hospital in Iran. Jundishapur J Microbiol. 2015;8(7):e19760.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the Pasteur Institute of Iran. The authors are grateful for the support of colleagues in the Bacteriology Departments in Pasteur Institute of Iran.

Funding

Not applicable.

Author information

Affiliations

Authors

Contributions

Contributions of the authors in this study were as follow: BM: Designing of study, interpretation of results and writing the manuscript. PF, MS, ME: Sample collection, Susceptibility testing, Perform laboratory tests. RS, FP: Sample collection, FH: Data Analysis, Proofreading; RB: wrist editing and interpretation of results. SF: Proofreading of the manuscript, data analysis. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Seyed Fazlollah Mousavi.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Pasteur Institute of Iran ethics committee All performed on the enlarged ethical statement B 9008 meeting number in Pasteur Institute of Iran. In this study, all ethics including Ethics and Consent to participate from their parents have been collected in the research. The informed consent obtained was written. To evaluate the specificity of PCR reaction, the standard strain of S. epidermidis 1457 was used as a positive control and Pseudomonas aeruginosa ATCC 27853 as a negative control (received from the Microbial Bank of Pasteur Institute of Iran).

Consent to publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Standardization of molecular test (PCR). Generated 388 bp sesc gene by PCR to S. epidermidis identification by 1% agarose gel (A). Standardization of biofilm-related genes ica Luci: icaA (103 bp), icaB (302 bp), icaC (400 bp), icaD (193 bp), sdrG (495 bp), and atlE (682 bp) by Multiplex colony PCR based on the size in 3% agarose gel (B). M; 100 bp DNA ladder, Lane 1-4; standardization of PCR for each targeted gene by colony PCR, Lane 5; standardization of semiplex PCR (two target genes), Lane 6; Multiplex colony PCR for ica Luci genes, Lane 7; optimization of Multiplex colony PCR for sdrG and atlE genes. Resulting PCR was visualized in a 1% agarose gel. (KBC, Max Pure agarose, Spain). S. epidermidis ATCC 12228 and Escherichia coli ATCC 25922 were used as the positive and negative control strains.

Additional file 2.

Sequences of utilized primers in this study.

Additional file 3.

Antibiotic resistance profile to biofilm-forming isolates. S; Susceptible, R; Resistant, N; the total number.

Additional file 4.

Frequency of antibiotic resistance pattern for MDR biofilm-forming S. epidermidis strains according to the utilized antibiotic. MA; Cefamandole, CTX; Cefotaxime, P; Penicillin, S; Streptomycin, AN; Amikacin, NB; Novobiocin, FOX; Cefoxitin, AMC; Amoxicillin/Clavulanic Acid, K; Kanamycin, CEC; Cefaclor.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mirzaei, B., Faridifar, P., Shahmoradi, M. et al. Genotypic and phenotypic analysis of biofilm formation Staphylococcus epidermidis isolates from clinical specimens. BMC Res Notes 13, 114 (2020). https://doi.org/10.1186/s13104-020-04965-y

Download citation

Keywords

  • Staphylococcus epidermidis
  • Biofilm-related genes
  • Multiplex colony PCR
  • atlE
  • sdrG
  • icaADCB